Skip to main content
Clinical Trials/NCT00394797
NCT00394797
Completed
Not Applicable

Surgical Correction of Moderate Ischemic Mitral Regurgitation

Shaare Zedek Medical Center1 site in 1 countryNovember 1, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Moderate Ischemic Mitral Regurgitation
Sponsor
Shaare Zedek Medical Center
Locations
1
Primary Endpoint
survival at 1,5 and 10 years
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.

Registry
clinicaltrials.gov
Start Date
November 1, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients undergoing coronary bypass surgery who have moderate degree of ischemic MR

Exclusion Criteria

  • etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.

Outcomes

Primary Outcomes

survival at 1,5 and 10 years

Secondary Outcomes

  • event free survival
  • echocardiographic parameters
  • symptoms

Study Sites (1)

Loading locations...

Similar Trials